Welcome to RxBiologics
At inception, human antibody phage display technology promised delivery of fully human antibodies, to any given target, directly from diverse antibody libraries. In reality, what transpired was a complex, iterative workflow of engineering phage-derived antibodies to correct for flaws in the affinity, stability and specificity of the initial hits.
RxBiologics have developed the Galaxy® proprietary library technology, invented by our co-founder Jonny Finlay. It revisits the fundaments of antibody discovery, rebuilding the process of human antibody discovery by display to eliminate its flaws and truly deliver on the original promise.
RxBiologics specialises in antibody drug discovery services for rapid generation of world-class biologics with optimal drug development qualities. We make Biologics drug discovery accessible to anyone with a great idea. We handle the complexity of drug discovery making it simple and effortless. Our approach is highly customisable to suit your deliverables and requirements.
Our dedicated team of technical experts have engineered and constructed the Galaxy® antibody library that underpins our proprietary platform.
Antibody drug discovery services for rapid generation of world-class biologics with optimal drug development qualities.
RxBiologics Galaxy® is a registered trademark in the United Kingdom
B950 Dorothy Hodgkin Building,
Babraham Research Campus,
Babraham, Cambridge CB22 3FH